ANI Pharmaceuticals, Inc.
ANIP
Cena:
Valuace
48
Růst
86
Zdraví
68
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 2.7 mil | 14.11% | 0.00% | 0.00% | 2024-09-30 |
| BLACKROCK INC. | 2.7 mil | 13.91% | 0.00% | 0.00% | 2014-06-30 |
| BLACKROCK, INC. | 2.7 mil | 13.70% | 0.00% | 0.00% | 2024-09-30 |
| VANGUARD GROUP INC | 1.3 mil | 6.50% | 0.00% | 0.00% | 2013-09-30 |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 820.24 tis | 4.09% | 1.14% | 2.55% | 2024-09-30 |
| STATE STREET CORP | 771.59 tis | 3.85% | 0.00% | 0.00% | 2013-06-30 |
| TANG CAPITAL MANAGEMENT LLC | 707.50 tis | 3.53% | 0.89% | 2.76% | 2024-03-31 |
| GOLDENTREE ASSET MANAGEMENT LP | 667.98 tis | 3.33% | 3.04% | 3.04% | 2026-03-31 |
| DEEP TRACK CAPITAL, LP | 600.00 tis | 2.99% | 0.08% | 0.75% | 2023-06-30 |
| MILLENNIUM MANAGEMENT LLC | 592.01 tis | 2.95% | 0.00% | 0.02% | 2021-09-30 |
| PACER ADVISORS, INC. | 568.34 tis | 2.93% | 0.07% | 0.07% | 2023-12-31 |
| CITADEL ADVISORS LLC | 580.09 tis | 2.92% | 0.00% | 0.01% | 2016-06-30 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 564.36 tis | 2.81% | 0.00% | 0.02% | 2025-09-30 |
| DIMENSIONAL FUND ADVISORS LP | 531.19 tis | 2.65% | 0.00% | 0.01% | 2013-09-30 |
| UBS GROUP AG | 497.70 tis | 2.48% | 0.00% | 0.01% | 2014-12-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 489.20 tis | 2.44% | 0.00% | 0.00% | 2013-09-30 |
| NUVEEN, LLC | 402.36 tis | 2.01% | 0.00% | 0.01% | 2025-03-31 |
| CAPTION MANAGEMENT, LLC | 400.00 tis | 1.99% | 0.07% | 0.18% | 2025-12-31 |
| GLOBAL ALPHA CAPITAL MANAGEMENT LTD. | 361.24 tis | 1.80% | -1.17% | 1.67% | 2021-09-30 |
| RANGER INVESTMENT MANAGEMENT, L.P. | 360.08 tis | 1.80% | 0.04% | 2.00% | 2017-03-31 |
| RUBRIC CAPITAL MANAGEMENT LP | 343.41 tis | 1.73% | 0.10% | 0.35% | 2021-12-31 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 327.28 tis | 1.63% | 0.01% | 0.08% | 2021-06-30 |
| INVESCO LTD. | 324.35 tis | 1.62% | 0.00% | 0.00% | 2014-06-30 |
| DEUTSCHE BANK AG\ | 319.68 tis | 1.59% | 0.00% | 0.01% | 2014-03-31 |
| 318.59 tis | 1.59% | 5.25% | 5.25% | 2026-03-31 | |
| MACQUARIE GROUP LTD | 291.13 tis | 1.47% | 0.00% | 0.03% | 2023-12-31 |
| KENNEDY CAPITAL MANAGEMENT LLC | 294.00 tis | 1.47% | 0.12% | 0.48% | 2022-06-30 |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 287.56 tis | 1.43% | 0.00% | 0.04% | 2025-12-31 |
| PARKMAN HEALTHCARE PARTNERS LLC | 280.58 tis | 1.40% | 1.14% | 2.23% | 2025-03-31 |
| AMERIPRISE FINANCIAL INC | 270.26 tis | 1.35% | 0.00% | 0.00% | 2014-06-30 |
| SIO CAPITAL MANAGEMENT, LLC | 265.54 tis | 1.32% | 1.84% | 2.93% | 2024-03-31 |
| FREESTONE GROVE PARTNERS LP | 254.23 tis | 1.27% | 0.06% | 0.14% | 2024-12-31 |
| THOMPSON SIEGEL & WALMSLEY LLC | 244.42 tis | 1.23% | 0.00% | 0.27% | 2020-03-31 |
| NOMURA HOLDINGS INC | 237.23 tis | 1.18% | 0.02% | 0.05% | 2024-09-30 |
| DIVISADERO STREET CAPITAL MANAGEMENT, LP | 234.22 tis | 1.18% | 0.94% | 0.94% | 2025-09-30 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 234.29 tis | 1.17% | 0.00% | 0.00% | 2014-06-30 |
| BANK OF MONTREAL /CAN/ | 230.07 tis | 1.15% | 0.00% | 0.01% | 2024-09-30 |
| OBERWEIS ASSET MANAGEMENT INC/ | 221.39 tis | 1.10% | -0.04% | 0.50% | 2023-09-30 |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 220.22 tis | 1.10% | 0.03% | 0.07% | 2023-06-30 |
| JPMORGAN CHASE & CO | 220.17 tis | 1.10% | 0.00% | 0.00% | 2016-03-31 |
| MORGAN STANLEY | 219.85 tis | 1.10% | 0.00% | 0.00% | 2013-12-31 |
| GOLDMAN SACHS GROUP INC | 219.76 tis | 1.10% | 0.00% | 0.00% | 2015-03-31 |
| ROYAL BANK OF CANADA | 213.92 tis | 1.07% | 0.00% | 0.00% | 2013-09-30 |
| D. E. SHAW & CO., INC. | 213.43 tis | 1.06% | 0.00% | 0.01% | 2024-06-30 |
| MIZUHO MARKETS AMERICAS LLC | 210.77 tis | 1.05% | 0.13% | 0.44% | 2024-09-30 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 210.13 tis | 1.05% | 0.00% | 0.02% | 2023-09-30 |
| MAN GROUP PLC | 208.69 tis | 1.04% | 0.02% | 0.03% | 2025-06-30 |
| ABRDN PLC | 206.12 tis | 1.03% | 0.00% | 0.03% | 2024-12-31 |
| BALYASNY ASSET MANAGEMENT L.P. | 205.09 tis | 1.02% | -0.01% | 0.02% | 2023-12-31 |
| APIS CAPITAL ADVISORS, LLC | 196.00 tis | 0.98% | -0.62% | 2.70% | 2025-03-31 |
| BNP PARIBAS ARBITRAGE, SNC | 193.57 tis | 0.96% | 0.00% | 0.01% | 2014-09-30 |
| AMERICAN CENTURY COMPANIES INC | 191.58 tis | 0.96% | 0.01% | 0.01% | 2023-06-30 |
| BARCLAYS PLC | 184.64 tis | 0.93% | 0.00% | 0.00% | 2013-09-30 |
| RENAISSANCE TECHNOLOGIES LLC | 186.10 tis | 0.93% | -0.02% | 0.02% | 2023-06-30 |
| SCHONFELD STRATEGIC ADVISORS LLC | 185.63 tis | 0.93% | 0.03% | 0.10% | 2025-03-31 |
| NORTHERN TRUST CORP | 184.85 tis | 0.92% | 0.00% | 0.00% | 2013-12-31 |
| WALLEYE CAPITAL LLC | 183.08 tis | 0.91% | 0.03% | 0.06% | 2024-06-30 |
| TWO SIGMA INVESTMENTS, LP | 181.15 tis | 0.90% | 0.01% | 0.02% | 2023-06-30 |
| PENN CAPITAL MANAGEMENT COMPANY, LLC | 179.72 tis | 0.90% | 0.21% | 1.07% | 2025-03-31 |
| CITIGROUP INC | 171.97 tis | 0.86% | 0.00% | 0.01% | 2014-06-30 |
| WOODLINE PARTNERS LP | 166.45 tis | 0.85% | 0.07% | 0.07% | 2024-09-30 |
| LOOMIS SAYLES & CO L P | 162.99 tis | 0.81% | 0.00% | 0.02% | 2023-03-31 |
| BANK OF AMERICA CORP /DE/ | 150.53 tis | 0.75% | 0.00% | 0.00% | 2013-09-30 |
| IKARIAN CAPITAL, LLC | 150.00 tis | 0.75% | 0.43% | 0.94% | 2025-12-31 |
| JANE STREET GROUP, LLC | 134.44 tis | 0.68% | 0.00% | 0.00% | 2022-12-31 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 128.69 tis | 0.65% | 0.02% | 0.04% | 2023-09-30 |
| RUSSELL INVESTMENTS GROUP, LTD. | 126.48 tis | 0.63% | 0.00% | 0.01% | 2019-09-30 |
| POINT72 ASSET MANAGEMENT, L.P. | 121.21 tis | 0.60% | -0.05% | 0.01% | 2025-09-30 |
| ASSENAGON ASSET MANAGEMENT S.A. | 114.62 tis | 0.58% | -0.02% | 0.01% | 2023-09-30 |
| BANK OF NEW YORK MELLON CORP | 112.64 tis | 0.56% | 0.00% | 0.00% | 2014-06-30 |
| BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC | 100.90 tis | 0.52% | -0.01% | 0.04% | 2019-03-31 |
| PRINCIPAL FINANCIAL GROUP INC | 98.49 tis | 0.50% | 0.00% | 0.00% | 2015-03-31 |
| RAYMOND JAMES FINANCIAL INC | 97.70 tis | 0.49% | 0.00% | 0.00% | 2024-12-31 |
| LISANTI CAPITAL GROWTH, LLC | 95.17 tis | 0.48% | -0.38% | 1.72% | 2024-03-31 |
| STEMPOINT CAPITAL LP | 85.38 tis | 0.45% | 1.26% | 1.26% | 2023-12-31 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 86.61 tis | 0.44% | -0.01% | 0.02% | 2024-09-30 |
| FIRST TRUST ADVISORS LP | 81.21 tis | 0.41% | 0.00% | 0.00% | 2024-06-30 |
| VICTORY CAPITAL MANAGEMENT INC | 79.70 tis | 0.40% | 0.00% | 0.00% | 2024-03-31 |
| WEISS ASSET MANAGEMENT LP | 76.51 tis | 0.40% | 0.18% | 0.18% | 2024-06-30 |
| WELLS FARGO & COMPANY/MN | 78.64 tis | 0.40% | 0.00% | 0.00% | 2014-03-31 |
| MARATHON CAPITAL MANAGEMENT | 72.03 tis | 0.36% | -0.04% | 1.20% | 2021-09-30 |
| HILLSDALE INVESTMENT MANAGEMENT INC. | 67.51 tis | 0.35% | 0.06% | 0.37% | 2023-06-30 |
| AYAL CAPITAL ADVISORS LTD | 66.72 tis | 0.34% | 1.48% | 1.48% | 2025-03-31 |
| GREAT LAKES ADVISORS, LLC | 64.80 tis | 0.33% | 0.00% | 0.04% | 2023-03-31 |
| RICE HALL JAMES & ASSOCIATES, LLC | 58.97 tis | 0.30% | -0.02% | 0.18% | 2023-06-30 |
| WEDGE CAPITAL MANAGEMENT L L P/NC | 58.68 tis | 0.30% | -0.01% | 0.06% | 2022-09-30 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 55.68 tis | 0.29% | 0.01% | 0.02% | 2022-09-30 |
| F/M INVESTMENTS LLC | 56.31 tis | 0.29% | -0.33% | 0.11% | 2024-09-30 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 53.10 tis | 0.27% | 0.01% | 0.01% | 2024-12-31 |
| J. GOLDMAN & CO LP | 51.12 tis | 0.27% | 0.11% | 0.11% | 2023-12-31 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 50.52 tis | 0.27% | 0.00% | 0.00% | 2021-06-30 |
| NUVEEN ASSET MANAGEMENT, LLC | 49.64 tis | 0.26% | 0.00% | 0.00% | 2019-06-30 |
| LEGAL & GENERAL GROUP PLC | 48.43 tis | 0.25% | 0.00% | 0.00% | 2014-12-31 |
| TREXQUANT INVESTMENT LP | 47.15 tis | 0.25% | 0.03% | 0.07% | 2023-03-31 |
| SEGALL BRYANT & HAMILL, LLC | 44.13 tis | 0.23% | 0.05% | 0.05% | 2024-06-30 |
| CLARIVEST ASSET MANAGEMENT LLC | 43.91 tis | 0.23% | -0.07% | 0.29% | 2023-06-30 |
| WELLINGTON MANAGEMENT GROUP LLP | 43.63 tis | 0.23% | 0.00% | 0.00% | 2023-12-31 |
| UBS ASSET MANAGEMENT AMERICAS INC | 42.97 tis | 0.23% | 0.00% | 0.00% | 2021-03-31 |
| RHUMBLINE ADVISERS | 42.17 tis | 0.22% | 0.00% | 0.00% | 2014-12-31 |
| HUSSMAN STRATEGIC ADVISORS, INC. | 42.00 tis | 0.22% | 0.23% | 0.74% | 2024-03-31 |
| COMERICA BANK | 36.66 tis | 0.19% | 0.00% | 0.01% | 2023-09-30 |
| ALGERT GLOBAL LLC | 36.58 tis | 0.19% | 0.07% | 0.10% | 2023-06-30 |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 33.73 tis | 0.18% | 0.00% | 0.01% | 2015-03-31 |
| SWISS NATIONAL BANK | 33.10 tis | 0.17% | 0.00% | 0.00% | 2015-06-30 |
| CREDIT SUISSE AG/ | 31.45 tis | 0.17% | 0.00% | 0.00% | 2014-03-31 |
| HRT FINANCIAL LP | 28.63 tis | 0.15% | 0.01% | 0.01% | 2023-12-31 |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 23.73 tis | 0.12% | 0.00% | 0.00% | 2015-03-31 |
| DEKABANK DEUTSCHE GIROZENTRALE | 23.02 tis | 0.12% | 0.00% | 0.00% | 2022-12-31 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 22.97 tis | 0.12% | 0.00% | 0.01% | 2023-06-30 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 22.75 tis | 0.12% | 0.00% | 0.00% | 2021-12-31 |
| MARTINGALE ASSET MANAGEMENT L P | 21.02 tis | 0.11% | 0.00% | 0.03% | 2021-12-31 |
| GREAT WEST LIFE ASSURANCE CO /CAN/ | 20.36 tis | 0.11% | 0.00% | 0.00% | 2016-06-30 |
| ALLIANZ ASSET MANAGEMENT GMBH | 19.50 tis | 0.10% | 0.00% | 0.00% | 2023-06-30 |
| PRUDENTIAL FINANCIAL INC | 18.55 tis | 0.10% | 0.00% | 0.00% | 2015-03-31 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | S-Sale | 500 | 78.16 | 13.5 2026 | 78390 |
| Gutwerg Ori | officer: SVP, GENERICS | S-Sale | 2772 | 79.50 | 13.5 2026 | 78696 |
| Lalwani Nikhil | director, officer: PRESIDENT & CEO | S-Sale | 55000 | 77.57 | 13.5 2026 | 349889 |
| Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | S-Sale | 459 | 79.21 | 13.5 2026 | 38271 |
| Walsh Patrick D | director | S-Sale | 10000 | 80.63 | 13.5 2026 | 38432 |
| Walsh Patrick D | director | S-Sale | 3973 | 80.75 | 13.5 2026 | 48432 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | S-Sale | 500 | 77.95 | 13.4 2026 | 78890 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | S-Sale | 500 | 72.62 | 13.3 2026 | 79390 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | S-Sale | 3162 | 71.64 | 13.3 2026 | 91309 |
| Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | S-Sale | 4772 | 74.91 | 13.3 2026 | 38730 |
| CAREY STEPHEN P. | officer: SVP & CFO | F-InKind | 5150 | 74.04 | 10.3 2026 | 180393 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | S-Sale | 5087 | 74.13 | 10.3 2026 | 51946 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | S-Sale | 1485 | 75.00 | 10.3 2026 | 57033 |
| Gutwerg Ori | officer: SVP, GENERICS | F-InKind | 3314 | 74.04 | 10.3 2026 | 81468 |
| Lalwani Nikhil | director, officer: PRESIDENT & CEO | F-InKind | 17060 | 74.04 | 10.3 2026 | 404889 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | S-Sale | 3602 | 74.18 | 10.3 2026 | 94471 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | F-InKind | 3314 | 74.04 | 10.3 2026 | 98073 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | S-Sale | 2121 | 74.22 | 10.3 2026 | 101387 |
| CAREY STEPHEN P. | officer: SVP & CFO | M-Exempt | 3312 | 49.51 | 5.3 2026 | 9938 |
| CAREY STEPHEN P. | officer: SVP & CFO | S-Sale | 4000 | 75.56 | 5.3 2026 | 185543 |
| CAREY STEPHEN P. | officer: SVP & CFO | S-Sale | 3312 | 75.42 | 5.3 2026 | 189543 |
| CAREY STEPHEN P. | officer: SVP & CFO | M-Exempt | 3312 | 49.51 | 5.3 2026 | 192855 |
| Gutwerg Ori | officer: SVP, GENERICS | S-Sale | 2060 | 76.50 | 4.3 2026 | 84782 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | S-Sale | 417 | 74.00 | 4.3 2026 | 103508 |
| Walsh Patrick D | director | S-Sale | 6000 | 74.23 | 3.3 2026 | 52405 |
| CAREY STEPHEN P. | officer: SVP & CFO | F-InKind | 2773 | 73.90 | 2.3 2026 | 189543 |
| CAREY STEPHEN P. | officer: SVP & CFO | A-Award | 22233 | 77.15 | 2.3 2026 | 192316 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | F-InKind | 1555 | 73.90 | 2.3 2026 | 79890 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | A-Award | 13895 | 77.15 | 2.3 2026 | 81445 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | F-InKind | 1555 | 73.90 | 2.3 2026 | 58518 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | A-Award | 10810 | 77.15 | 2.3 2026 | 60073 |
| Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | F-InKind | 2221 | 73.90 | 2.3 2026 | 74916 |
| Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | A-Award | 11116 | 77.15 | 2.3 2026 | 77137 |
| Gutwerg Ori | officer: SVP, GENERICS | F-InKind | 2221 | 73.90 | 2.3 2026 | 86842 |
| Gutwerg Ori | officer: SVP, GENERICS | A-Award | 12969 | 77.15 | 2.3 2026 | 89063 |
| Lalwani Nikhil | director, officer: PRESIDENT & CEO | F-InKind | 12217 | 73.90 | 2.3 2026 | 421949 |
| Lalwani Nikhil | director, officer: PRESIDENT & CEO | A-Award | 75592 | 77.15 | 2.3 2026 | 434166 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | F-InKind | 2221 | 73.90 | 2.3 2026 | 103925 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | A-Award | 21306 | 77.15 | 2.3 2026 | 106146 |
| Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | F-InKind | 628 | 73.90 | 2.3 2026 | 43502 |
| Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | A-Award | 6021 | 77.15 | 2.3 2026 | 44130 |
| Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | A-Award | 11116 | 77.15 | 2.3 2026 | 101056 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | S-Sale | 1730 | 77.99 | 23.2 2026 | 49263 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | S-Sale | 2084 | 77.53 | 23.2 2026 | 50993 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | S-Sale | 5323 | 78.02 | 23.2 2026 | 84840 |
| CAREY STEPHEN P. | officer: SVP & CFO | F-InKind | 2448 | 77.36 | 17.2 2026 | 170083 |
| CAREY STEPHEN P. | officer: SVP & CFO | F-InKind | 2829 | 76.70 | 17.2 2026 | 172531 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | F-InKind | 1779 | 77.36 | 17.2 2026 | 67550 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | S-Sale | 500 | 76.80 | 17.2 2026 | 69329 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | F-InKind | 1534 | 76.70 | 17.2 2026 | 69829 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | F-InKind | 1290 | 77.36 | 17.2 2026 | 53077 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | F-InKind | 1180 | 76.70 | 17.2 2026 | 54367 |
| Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | F-InKind | 1717 | 77.36 | 17.2 2026 | 66021 |
| Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | F-InKind | 1608 | 76.70 | 17.2 2026 | 67738 |
| Gutwerg Ori | officer: SVP, GENERICS | F-InKind | 1888 | 77.36 | 17.2 2026 | 76094 |
| Gutwerg Ori | officer: SVP, GENERICS | F-InKind | 1775 | 76.70 | 17.2 2026 | 77982 |
| Lalwani Nikhil | director, officer: PRESIDENT & CEO | F-InKind | 10298 | 77.36 | 17.2 2026 | 358574 |
| Lalwani Nikhil | director, officer: PRESIDENT & CEO | F-InKind | 11688 | 76.70 | 17.2 2026 | 368872 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | F-InKind | 2403 | 77.36 | 17.2 2026 | 90163 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | S-Sale | 7032 | 76.55 | 17.2 2026 | 92566 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | F-InKind | 3173 | 76.70 | 17.2 2026 | 99598 |
| Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | F-InKind | 485 | 77.36 | 17.2 2026 | 38109 |
| Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | F-InKind | 566 | 76.70 | 17.2 2026 | 38594 |
| Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | F-InKind | 2898 | 76.25 | 13.2 2026 | 89940 |
| Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | F-InKind | 1762 | 76.25 | 13.2 2026 | 39160 |
| Mutz Christopher | officer: HEAD OF RARE DISEASE | F-InKind | 4546 | 76.25 | 13.2 2026 | 102771 |
| Lalwani Nikhil | director, officer: PRESIDENT & CEO | F-InKind | 30659 | 76.25 | 13.2 2026 | 380560 |
| Gutwerg Ori | officer: SVP, GENERICS | F-InKind | 4267 | 76.25 | 13.2 2026 | 79757 |
| Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | F-InKind | 4269 | 76.25 | 13.2 2026 | 69346 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | F-InKind | 3017 | 76.25 | 13.2 2026 | 55547 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | F-InKind | 3011 | 76.25 | 13.2 2026 | 71363 |
| CAREY STEPHEN P. | officer: SVP & CFO | F-InKind | 5503 | 76.25 | 13.2 2026 | 175360 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | S-Sale | 500 | 84.33 | 14.1 2026 | 74374 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | S-Sale | 1622 | 82.40 | 19.12 2025 | 58564 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | S-Sale | 400 | 82.32 | 12.12 2025 | 74874 |
| TANNENBAUM RENEE P | director | S-Sale | 1800 | 81.15 | 9.12 2025 | 25157 |
| Walsh Patrick D | director | G-Gift | 3000 | 0.00 | 17.11 2025 | 58405 |
| Walsh Patrick D | director | S-Sale | 8643 | 86.88 | 17.11 2025 | 61405 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | S-Sale | 400 | 87.27 | 14.11 2025 | 75274 |
| Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | S-Sale | 94 | 88.00 | 14.11 2025 | 158490 |
| Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | S-Sale | 14642 | 89.07 | 14.11 2025 | 158584 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | S-Sale | 400 | 90.09 | 14.10 2025 | 75674 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | S-Sale | 1000 | 98.04 | 22.9 2025 | 60186 |
| Cook Meredith | officer: SR. VP, GENERAL COUNSEL & SEC. | S-Sale | 400 | 98.42 | 15.9 2025 | 76074 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | F-InKind | 1710 | 97.71 | 15.9 2025 | 61186 |
| Pera Antonio R | director | S-Sale | 7292 | 94.94 | 4.9 2025 | 22660 |
| Leonard Matthew J | director | S-Sale | 2528 | 90.62 | 26.8 2025 | 6864 |
| Davis Krista | officer: SVP, CHIEF HR OFFICER | S-Sale | 1763 | 91.10 | 25.8 2025 | 62896 |
| Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | S-Sale | 52988 | 90.44 | 22.8 2025 | 431920 |
| Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | S-Sale | 47012 | 90.27 | 22.8 2025 | 484908 |
| Pera Antonio R | director | S-Sale | 5421 | 89.73 | 20.8 2025 | 29952 |
| Thoma Jeanne | director | S-Sale | 14675 | 88.87 | 20.8 2025 | 23405 |
| Thoma Jeanne | director | S-Sale | 6865 | 89.76 | 20.8 2025 | 38080 |
| Gassert Chad | officer: SVP - CORP. DEV. & STRATEGY | S-Sale | 20000 | 86.97 | 18.8 2025 | 173226 |
| Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | S-Sale | 52990 | 87.15 | 18.8 2025 | 531920 |
| Shanmugam Muthusamy | director, officer: HEAD OF R&D, COO-NOVITIUM OPS | S-Sale | 47010 | 89.48 | 18.8 2025 | 584910 |
| Walsh Patrick D | director | S-Sale | 9000 | 89.05 | 18.8 2025 | 70048 |
| Leonard Matthew J | director | S-Sale | 6937 | 88.17 | 18.8 2025 | 9392 |
| Lalwani Nikhil | director, officer: PRESIDENT & CEO | S-Sale | 56960 | 85.93 | 14.8 2025 | 411219 |
| Rowland Thomas Andrew | officer: SVP, HEAD - ESTABLISHED BRANDS | S-Sale | 4975 | 85.71 | 14.8 2025 | 40794 |
